We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$22.9M
Cap. Flow
+$49.3M
Cap. Flow %
12.82%
Top 10 Hldgs %
35.81%
Holding
89
New
18
Increased
39
Reduced
11
Closed
18

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$9.14M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$7.54M
3
GH icon
Guardant Health
GH
+$6.84M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.76M
5
MRK icon
Merck
MRK
+$5.91M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$13.7M
2
ABT icon
Abbott
ABT
+$9.85M
3
FATE icon
Fate Therapeutics
FATE
+$7.61M
4
ABBV icon
AbbVie
ABBV
+$6.77M
5
LH icon
Labcorp
LH
+$6.28M

Sector Composition

Rank Sector Weight
1 Healthcare 97.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
1
Elevance Health
ELV
$84.8B
$22.1M 5.75%
45,000
+20,000
+80% +$9.14M
CYTK icon
2
Cytokinetics
CYTK
$10.7B
$17.3M 4.5%
470,000
+145,000
+45% +$5.15M
PFE icon
3
Pfizer
PFE
$147B
$15.5M 4.04%
300,000
+100,000
+50% +$5.19M
GMED icon
4
Globus Medical
GMED
$11.1B
$13.3M 3.46%
180,000
– –
RVTY icon
5
Revvity
RVTY
$12.8B
$13.1M 3.4%
75,000
+5,000
+7% +$888K
CNC icon
6
Centene
CNC
$33.1B
$12.6M 3.29%
150,000
-75,000
-33% -$6.15M
NVST icon
7
Envista
NVST
$4.66B
$12.2M 3.17%
250,000
-50,000
-17% -$2.31M
THC icon
8
Tenet Healthcare
THC
$21.1B
$11.2M 2.91%
130,000
+50,000
+63% +$4.11M
SAGE
9
DELISTED
Sage Therapeutics
SAGE
$10.3M 2.68%
311,000
-98,000
-24% -$3.68M
CCXI
10
DELISTED
ChemoCentryx, Inc.
CCXI
$10M 2.61%
400,000
+200,000
+100% +$5.62M
ZNTL icon
11
Zentalis Pharmaceuticals
ZNTL
$352M
$9.92M 2.58%
215,000
+95,000
+79% +$5.12M
ACHC icon
12
Acadia Healthcare
ACHC
$3B
$9.83M 2.56%
150,000
+30,000
+25% +$1.74M
RLAY icon
13
Relay Therapeutics
RLAY
$4.29B
$9.79M 2.55%
327,000
+102,000
+45% +$2.47M
BPMC
14
DELISTED
Blueprint Medicines
BPMC
$9.77M 2.54%
153,000
+78,000
+104% +$5.6M
IRTC icon
15
iRhythm Holdings
IRTC
$4.09B
$9.45M 2.46%
60,000
+20,000
+50% +$2.57M
CVS icon
16
CVS Health
CVS
$126B
$9.11M 2.37%
90,000
+5,000
+6% +$525K
CRSP icon
17
CRISPR Therapeutics
CRSP
$5.07B
$7.53M 1.96%
+120,000
New +$7.54M
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
$7.2M 1.87%
+50,000
New +$6.76M
AMED
19
DELISTED
Amedisys
AMED
$6.89M 1.79%
40,000
-10,000
-20% -$1.49M
AZN icon
20
AstraZeneca
AZN
$250B
$6.63M 1.73%
50,000
– –
GH icon
21
Guardant Health
GH
$21.9B
$6.62M 1.72%
+100,000
New +$6.84M
ALKS icon
22
Alkermes
ALKS
$8.32B
$6.58M 1.71%
250,000
+200,000
+400% +$4.95M
SWAV
23
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$6.22M 1.62%
+30,000
New +$4.95M
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.6B
$6.17M 1.61%
80,000
+32,000
+67% +$2.68M
MRK icon
25
Merck
MRK
$317B
$6.15M 1.6%
+75,000
New +$5.91M
1
2 3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Integral Health Asset Management held 89 positions worth $384M, up 6.3% from $361M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management deployed $49.3M of net new capital in Q1 2022, opening 18 new positions and adding to 39 existing holdings. Its largest new stake was CRISPR Therapeutics: 120,000 shares worth $7.53M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 97% a quarter earlier.

On the sell side, the largest reduction was Centene, an estimated $6.15M trimmed.

  • Integral Health Asset Management's largest Q1 2022 buy was CRISPR Therapeutics: 120,000 shares worth $7.53M.
  • Integral Health Asset Management added most to Elevance Health in Q1 2022, an estimated $9.14M increase.
  • Integral Health Asset Management's biggest Q1 2022 reduction was Centene, cutting an estimated $6.15M.
  • Integral Health Asset Management fully exited McKesson in Q1 2022, selling an estimated $13.7M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $384M portfolio in Q1 2022.
  • Integral Health Asset Management opened 18 new positions and closed 18 in Q1 2022.
  • Integral Health Asset Management's portfolio value rose 6.3% quarter-over-quarter to $384M.

Based on Integral Health Asset Management's 13F filing for Q1 2022, filed 12 May 2022.